Stockreport

Neurocrine to acquire Prader-Will drug in $2.9B Soleno buyout [Yahoo! Finance]

Neurocrine Biosciences, Inc.  (NBIX) 
Last neurocrine biosciences, inc. earnings: 2/4 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: neurocrine.com/about-us/webcasts-presentations
PDF Neurocrine Biosciences is wagering on the financial upside of a first-of-its kind treatment for the rare disease Prader-Willi syndrome, agreeing on Monday to acquire th [Read more]